SCOPUS 정보 검색 플랫폼

Breast Cancer Research

Volumn 4, Issue 1, 2002, Pages 24-29

The present and future role of bisphosphonates in the management of patients with breast cancer

(2) Brown, Janet E a Coleman, Robert E a

a Academic Unit of Clinical Oncology (United Kingdom)

Author keywords

Bisphosphonates; Breast cancer; Cancer induced bone disease

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; IBANDRONIC ACID; OSTEOPROTEGERIN; PAMIDRONIC ACID; PLACEBO; ZOLEDRONIC ACID;

BONE METASTASIS; BONE PAIN; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCALCEMIA; MEDICAL RESEARCH; MORBIDITY; OSTEOPOROSIS; PATHOLOGIC FRACTURE; REVIEW;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; MEDICAL ONCOLOGY; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036150322 PISSN: 14655411 EISSN: None Source Type: Journal
DOI: 10.1186/bcr413 Document Type: Review

Times cited : (45)

References (25)

1
- 0033050818
- Pamidronate reduces skeletal morbidity in women with advance breast cancer and lytic bone lesions: A randomised, placebo-controlled trial
- (1999) J. Clin. Oncol. , vol.17 , pp. 846-854
- Theriault, R.L.¹ Lipton, A.² Hortobagyi, G.N.³ Leff, R.⁴ Gluck, S.⁵ Stewart, J.F.⁶ Costello, S.⁷ Kennedy, I.⁸ Simeone, J.⁹ Seman, J.J.¹⁰ Knight, R.D.¹¹ Mellars, K.¹² Heffernan, M.¹³ Reitsma, D.J.¹⁴

2
- 10544228130
- Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
- (1996) N. Engl. J. Med. , vol.335 , pp. 1785-1791
- Hortobagyi, G.N.¹ Theriault, R.L.² Porter, L.³ Blayney, D.⁴ Lipton, A.⁵ Sinoff, C.⁶ Wheeler, H.⁷ Simeone, J.F.⁸ Seaman, J.⁹ Knight, R.D.¹⁰

3
- 0033663602
- Management of bone metastases
- (2000) The Oncologist , vol.5 , pp. 463-470
- Coleman, R.E.¹

4
- 0035863508
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomised, controlled clinical trials
- (2001) J. Clin. Oncol. , vol.19 , pp. 558-567
- Major, P.¹ Lortholary, A.² Hon, J.³ Abdi, E.⁴ Mills, G.⁵ Menssen, H.D.⁶ Yunus, F.⁷ Bell, R.⁸ Body, J.⁹ Quebe-Fehling, E.¹⁰ Seaman, J.¹¹

5
- 0035312469
- Zoledronic acid reduces skeletal related events in patients with osteolytic metastases: A double-blind, randomised dose-response study
- (2001) Cancer , vol.91 , pp. 1191-1200
- Berenson, J.R.¹ Rosen, L.S.² Howell, A.³ Porter, L.⁴ Coleman, R.E.⁵ Morley, W.⁶ Dreicer, R.⁷ Kuross, S.A.⁸ Lipton, A.⁹ Seaman, J.J.¹⁰

6
- 0000460083
- Zometa is equivalent to pamidronate in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy
- [abstract]
- (2001) Eur. J. Cancer , vol.37 , Issue.6
- Coleman, R.¹ Apffelstaedt, J.² Major, P.³ Mackey, J.⁴ Howell, A.⁵ Theriault, R.⁶ Gordon, D.⁷ Ambros, Y.⁸

7
- 0000452803
- Double-blind placebo controlled trial of ibandronate in breast cancer metastatic to bone
- [abstract]
- (1999) Proc. ASCO , vol.18
- Body, J.J.¹ Lichinitser, M.R.² Diehl, I.E.³ Schlosser, K.⁴ Pfarr, E.⁵ Cavalli, V.⁶ Dornoff, V.⁷ Gorbuova, V.A.⁸ McCloskey, E.⁹ Weiss, J.¹⁰ Kanis, J.A.¹¹

8
- 0032956195
- Double-blind, randomised, placebo-controlled study of oral ibandronate in patients with metastatic bone disease
- (1999) Ann. Oncol. , vol.10 , pp. 311-316
- Coleman, R.E.¹ Purohit, O.P.² Black, C.³ Vinholes, J.J.⁴ Schlosser, K.⁵ Huss, H.⁶ Quinn, K.J.⁷ Kanis, J.⁸

9
- 0032434254
- Current use of bisphosphonates in oncology
- International Bone and Cancer Study Group.
- (1998) J. Clin. Oncol. , vol.16 , pp. 3890-3899
- Body, J.J.¹ Bartl, R.² Burckhardt, P.³ Delmas, P.D.⁴ Diel, I.J.⁵ Fleish, H.⁶ Kanis, J.A.⁷ Kyle, R.A.⁸ Mundy, G.R.⁹ Paterson, A.H.¹⁰ Rubens, R.D.¹¹

10
- 0035178874
- Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease
- (in press)
- (2001) Ann. Oncol.
- Jagdev, S.P.¹ Purohit, O.P.² Heatley, S.³ Herling, C.⁴ Coleman, R.E.⁵

11
- 0000894762
- Phase I clinical study of a new bisphosphonate, zoledronate (CGP-42446), in patients with osteolytic bone metastases
- [abstract]
- (1998) Blood , vol.88 , Issue.SUPPL. 1
- Berenson, J.R.¹ Lipton, A.² Rosen, L.S.³

12
- 7144264425
- Relationships between biochemical and symptomatic response in a double-blind trial of pamidronate for metastatic bone disease
- (1997) Ann. Oncol. , vol.8 , pp. 1243-1250
- Vinholes, J.J.¹ Purohit, O.P.² Abbey, M.E.³ Eastell, R.⁴ Coleman, R.E.⁵

13
- 0000414237
- Continual oral versus intravenous interval therapy with bisphosphonates in patients with breast cancer and bone metastases
- [abstract]
- (1999) Proc ASCO , vol.18 , pp. 128
- Diel, I.J.¹ Marschner, N.² Kindler, M.³ Lange, O.⁴ Untch, M.⁵ Hurtz, H.J.⁶ Breitbach, G.P.⁷ Richter, B.⁸

14
- 0029782630
- Delay in progression of bone metastases treated with intravenous pamidronate: Results from a multicentre randomised controlled trial
- (1996) J. Clin. Oncol. , vol.14 , pp. 2552-2559
- Conte, P.F.¹ Latreille, J.² Mauriac, L.³ Calabresi, F.⁴ Santos, R.⁵ Campos, D.⁶ Bonneterre, J.⁷ Francini, G.⁸ Ford, J.M.⁹

15
- 0030483518
- Efficacy of pamidronate on skeletal complications from breast cancer metastases. A randomised prospective double blind placebo controlled trial
- (1996) Acta. Oncol. , vol.35 , Issue.SUPPL. 5 , pp. 73-74
- Hultborn, R.¹ Ryden, S.² Gunderson, S.³ Holmberg, E.⁴ Wallgren, U.-B.⁵

16
- 0034162528
- Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast cancer and osteolytic bone metastases: Long-term results of two randomised, placebo-controlled trials
- (2000) Cancer , vol.88 , pp. 1082-1090
- Lipton, A.¹ Theriault, R.L.² Hortobagyi, G.N.³ Simeone, J.⁴ Knight, R.D.⁵ Mellars, K.⁶ Reitsma, D.J.⁷ Heffernan, M.⁸ Seamann, J.J.⁹

17
- 17044446655
- Markers of bone resorption in patients treated with pamidronate
- (1998) Eur. J. Cancer , vol.34 , pp. 2021-2026
- Lipton, A.¹ Demers, L.² Curley, E.³ Chinchilli, V.⁴ Gaydos, L.⁵ Hortobagyi, G.⁶ Theriault, R.⁷ Clemens, D.⁸ Costa, L.⁹ Seaman, J.¹⁰ Knight, R.¹¹

18
- 0007961304
- Osteoporosis in cancer patients
- Edited by Rubens RD, Mundy GR. London: Martin Dunitz Ltd
- (2000) Cancer and the Skeleton , pp. 263-270
- Fontana, A.¹ Delmas, P.D.²

19
- 0000292633
- Adjuvant clodronate reduces the incidence of bone metastases in patients with primary operable breast cancer
- [abstract]
- (1998) Proc. ASCO , vol.17 , pp. 468
- Powles, T.J.¹ Paterson, A.H.G.² Nevantaus, A.³ Legault, S.⁴ Pajunen, M.⁵ Tidy, V.A.⁶ Rosenquist, K.⁷ Smith, I.E.⁸ Ottestad, L.⁹ Ashley, S.¹⁰ Walsh, G.¹¹ McCloskey, E.¹² Kanis, J.A.¹³

20
- 0032491037
- Reduction in new metastases in breast cancer with adjuvant clodronate treatment
- (1998) N. Engl. J. Med. , vol.339 , pp. 357-363
- Diel, I.¹ Solomayer, E.F.² Costa, S.D.³ Gollan, C.⁴ Goerner, R.⁵ Wallwiener, D.⁶ Kaufmann, M.⁷ Bastert, G.⁸

21
- 0035148170
- Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial
- (2001) J. Clin. Oncol. , vol.19 , pp. 10-17
- Saarto, T.¹ Blomqvist, C.² Virkkunen, P.³ Eloma, A.⁴

22
- 0033611467
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
- (1999) Nature , vol.397 , pp. 315-323
- Kong, Y.Y.¹ Yoshida, H.² Sarosi, I.³ Tan, H.L.⁴ Timms, E.⁵ Morony, S.⁶ Oliveira-dos-Santos, A.J.⁷ Van, G.⁸ Itie, A.⁹ Khoo, W.¹⁰ Wakeham, A.¹¹ Dunstan, C.R.¹² Lacey, D.I.¹³ Mak, T.W.¹⁴ Boyle, W.J.¹⁵ Penninger, J.M.¹⁶

23
- 0034105966
- Osteoprotogerin blocks bone cancer-induced skeletal destruction. Skeletal pain and pain-related neurochemical re-organisation of the spinal cord
- (2000) Nat. Med. , vol.6 , pp. 521-528
- Honore, P.¹ Luger, N.M.² Sabino, A.C.³ Schwei, M.J.⁴ Rogers, S.D.⁵ Mach, D.B.⁶ O'Keefe, P.F.⁷ Ramnaraine, M.L.⁸ Clohisy, D.R.⁹ Mantyh, P.W.¹⁰

24
- 0023200599
- Reduced morbidity from skeletal metastases in breast cancer patients during long term bisphosphonate (APD) treatment
- (1987) Lancet , vol.2 , pp. 983-985
- van Holten-Verzantvoort, A.T.¹ Bijvoet, O.L.M.² Cleton, F.J.³ Hermans, J.⁴ Kroon, H.M.⁵ Harinck, H.I.⁶ Vermey, P.⁷ Elte, J.W.⁸ Neijt, J.P.⁹ Beex, L.V.¹⁰

25
- 0027531814
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
- (1993) J. Clin. Oncol. , vol.11 , pp. 59-65
- Paterson, A.H.G.¹ Powles, T.J.² Kanis, J.A.³ McCloskey, E.⁴ Hanson, J.⁵ Ashley, S.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.